Director/PDMR Shareholding

09 April 2018 Oxford Instruments plc, a leading provider of high-technology solutions, information and services for industry and research, was notified on 9 April 2018 that on 6 April 2018 certain purchases and awards of ordinary shares of 5 pence each in the capital of the Company were made under the all-employee Oxford Instruments Share... Read more

Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018

Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018 SANTA CLARA, Calif., April 9, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it will showcase its line-up of innovative solutions for laboratory efficiency at Analytica, being held April 10 – 13, in Munich, Germany. This year at the 26th international trade fair for... Read more

Neogen chairman to gift stock

LANSING, Mich., April 6, 2018 /PRNewswire/ — Neogen Corporation (NASDAQ: NEOG) announced today that Executive Chairman James Herbert intends to make a significant gift of Neogen stock to a charitable organization that he and his wife have supported for many years. The company advised that according to Herbert’s plan the stock gift might be as much as 400,000 shares... Read more

PerkinElmer Prices Offering of Euro-Denominated Senior Notes

April 4, 2018 at 4:15 PM EDT PDF Version WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 4, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of €300 million aggregate principal amount of 0.600% Senior Notes due 2021 at an issue price of 99.950% of the principal... Read more

Dr. David Sinclair Joins Zymo Research Corp.’s Scientific Advisory Board

One of the most important thought leaders in the aging field Dr. David A. Sinclair, an anti-aging specialist, joins Zymo Research’s Scientific Advisory Board. IRVINE, Calif., April 3, 2018 /PRNewswire/ — The Zymo Research Corp. Board of Directors has announced the appointment of David A. Sinclair, Ph.D., O.A., Professor, Principal Investigator and Co-Director of the Paul F. Glenn Labs... Read more

Waters Corporation to Invest $215 Million in Precision Chemistry Manufacturing in Massachusetts

New State-of-the-Art Facility Will Support Continued Growth and Innovation MILFORD, Mass.–(BUSINESS WIRE)–Apr. 3, 2018– Following recent approval by its Board of Directors, Waters Corporation (NYSE: WAT) announced plans to significantly expand its precision chemistry operation in Taunton, Mass. The company anticipates investing approximately $215 million to build and equip a new state-of-the-art facility that will support rising global customer demand, as... Read more

Twist Bioscience Completes $50 Million Financing to Fuel Advancement of Digital Storage in DNA and Drug Discovery

Download PDF SAN FRANCISCO, Calif. – April 2, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the completion of a private placement of $50 million, bringing the total raised to $259 million since the company’s founding in 2013. “We have used our proprietary DNA... Read more

Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live longer compared to Avastin plus carboplatin and paclitaxel

Basel, 26 March 2018 Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live longer compared to Avastin plus carboplatin and paclitaxel These additional data will be submitted to health authorities globally, including the U.S. Food and Drug Administration (FDA) and European Medicines... Read more